Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine

Alan Woelfel, Roy A. Kaplan, Charles Y C Pak

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effect of hydrochlorothiazide on the formation of renal stones was evaluated by quantitative assessment of the propensity of urine to undergo crystallization of calcium oxalate. In seven patients with calcium urolithiasis (three with absorptive hypercalciuria, one with renal hypercalciuria, and three with normocalciuric nephrolithiasis), the urinary activity product ratio and formation product ratio of calcium oxalate were measured both on and off therapy with hydrochlorothiazide (50 mg orally twice a day). The activity product ratio (state of saturation with respect to calcium oxalate) decreased in the majority of cases, primarily as a result of the fall in urinary calcium. The formation product ratio (limit of metastability) increased in all cases; the cause of the increase was not readily apparent. Both changes reduced the propensity of urine to undergo crystallization of calcium oxalate, and therefore may account for the clinical improvement reported during thiazide therapy in nephrolithiasis.

Original languageEnglish (US)
Pages (from-to)201-205
Number of pages5
JournalMetabolism
Volume26
Issue number2
DOIs
StatePublished - 1977

Fingerprint

Calcium Oxalate
Hydrochlorothiazide
Crystallization
Urine
Hypercalciuria
Nephrolithiasis
Calcium
Thiazides
Kidney
Urolithiasis
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine. / Woelfel, Alan; Kaplan, Roy A.; Pak, Charles Y C.

In: Metabolism, Vol. 26, No. 2, 1977, p. 201-205.

Research output: Contribution to journalArticle

@article{8e91dba1770f45fabd0642e9ed388772,
title = "Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine",
abstract = "The effect of hydrochlorothiazide on the formation of renal stones was evaluated by quantitative assessment of the propensity of urine to undergo crystallization of calcium oxalate. In seven patients with calcium urolithiasis (three with absorptive hypercalciuria, one with renal hypercalciuria, and three with normocalciuric nephrolithiasis), the urinary activity product ratio and formation product ratio of calcium oxalate were measured both on and off therapy with hydrochlorothiazide (50 mg orally twice a day). The activity product ratio (state of saturation with respect to calcium oxalate) decreased in the majority of cases, primarily as a result of the fall in urinary calcium. The formation product ratio (limit of metastability) increased in all cases; the cause of the increase was not readily apparent. Both changes reduced the propensity of urine to undergo crystallization of calcium oxalate, and therefore may account for the clinical improvement reported during thiazide therapy in nephrolithiasis.",
author = "Alan Woelfel and Kaplan, {Roy A.} and Pak, {Charles Y C}",
year = "1977",
doi = "10.1016/0026-0495(77)90056-7",
language = "English (US)",
volume = "26",
pages = "201--205",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine

AU - Woelfel, Alan

AU - Kaplan, Roy A.

AU - Pak, Charles Y C

PY - 1977

Y1 - 1977

N2 - The effect of hydrochlorothiazide on the formation of renal stones was evaluated by quantitative assessment of the propensity of urine to undergo crystallization of calcium oxalate. In seven patients with calcium urolithiasis (three with absorptive hypercalciuria, one with renal hypercalciuria, and three with normocalciuric nephrolithiasis), the urinary activity product ratio and formation product ratio of calcium oxalate were measured both on and off therapy with hydrochlorothiazide (50 mg orally twice a day). The activity product ratio (state of saturation with respect to calcium oxalate) decreased in the majority of cases, primarily as a result of the fall in urinary calcium. The formation product ratio (limit of metastability) increased in all cases; the cause of the increase was not readily apparent. Both changes reduced the propensity of urine to undergo crystallization of calcium oxalate, and therefore may account for the clinical improvement reported during thiazide therapy in nephrolithiasis.

AB - The effect of hydrochlorothiazide on the formation of renal stones was evaluated by quantitative assessment of the propensity of urine to undergo crystallization of calcium oxalate. In seven patients with calcium urolithiasis (three with absorptive hypercalciuria, one with renal hypercalciuria, and three with normocalciuric nephrolithiasis), the urinary activity product ratio and formation product ratio of calcium oxalate were measured both on and off therapy with hydrochlorothiazide (50 mg orally twice a day). The activity product ratio (state of saturation with respect to calcium oxalate) decreased in the majority of cases, primarily as a result of the fall in urinary calcium. The formation product ratio (limit of metastability) increased in all cases; the cause of the increase was not readily apparent. Both changes reduced the propensity of urine to undergo crystallization of calcium oxalate, and therefore may account for the clinical improvement reported during thiazide therapy in nephrolithiasis.

UR - http://www.scopus.com/inward/record.url?scp=0017363276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017363276&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(77)90056-7

DO - 10.1016/0026-0495(77)90056-7

M3 - Article

C2 - 834153

AN - SCOPUS:0017363276

VL - 26

SP - 201

EP - 205

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 2

ER -